Adtalem Global Education (NYSE:CVSA) Cut to Hold at Zacks Research

Zacks Research lowered shares of Adtalem Global Education (NYSE:CVSA) from a strong-buy rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports.

Other equities research analysts have also recently issued research reports about the stock. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, March 2nd. Weiss Ratings assumed coverage on shares of Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Finally, Truist Financial assumed coverage on shares of Adtalem Global Education in a research note on Tuesday. They issued a “buy” rating and a $130.00 price target for the company. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and an average target price of $150.00.

Adtalem Global Education Price Performance

Shares of NYSE CVSA opened at $114.39 on Wednesday. The stock has a market cap of $3.95 billion, a P/E ratio of 16.80, a PEG ratio of 0.99 and a beta of 0.72. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.68 and a current ratio of 0.68. Adtalem Global Education has a 1-year low of $86.97 and a 1-year high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share (EPS) for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.The business had revenue of $503.39 million during the quarter.

Insider Activity at Adtalem Global Education

In other news, Director Michael W. Malafronte purchased 15,305 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was bought at an average cost of $100.86 per share, for a total transaction of $1,543,662.30. Following the acquisition, the director directly owned 16,505 shares of the company’s stock, valued at $1,664,694.30. This represents a 1,275.42% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders have acquired 37,236 shares of company stock valued at $3,752,866 over the last quarter. 2.50% of the stock is owned by insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.